Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve unaudited standalone & consolidated ....
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories has informed BSE that its Board of Directors will meet on Wednesday, 11th February 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025. This is a routine regulatory intimation under SEBI Listing Regulations ahead of the upcoming Q3 earnings announcement. The company's trading window for insiders has been closed from 1st January 2026 to 13th February 2026 in line with insider trading norms. The actual financial numbers are not disclosed in this filing and will only be released after the board meeting.
Neutral in the short term — this is a procedural notice confirming an upcoming results announcement, not a material business update. Investors should watch for the actual Q3FY26 results on 11th February for revenue, profit, and margin trends.